HIGHLIGHTS
- who: (on-line and colleagues from the National Cancer Institute have published the article: Expresion paterns of various PDCD1 and PDL1 isoforms in prostate tumors, in the Journal: (JOURNAL)
- what: The authors propose to assess the RE levels of the PDCD1 and PDL1 genes long isoforms before prescribing immunotherapy methods to analyse the putative sensitivity of tumors to such treatment. The aim of this work was to investigate the relation between the expression patterns of various PDL1 and PDCD1 isoforms and the clinico-pathological characteristics of prostate tumor samples, to study their role in the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.